Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 36,655 | 40,190 | 44,820 | 46,666 | 49,461 |
| Cost of Goods | 34,133 | 38,100 | 40,882 | 47,278 | 47,881 |
| Gross Profit | 2,522 | 2,090 | 3,938 | -612 | 1,580 |
| Operating Expenses | 3,926 | 3,803 | 4,612 | 4,372 | 5,317 |
| Operating Income | -1,271 | -1,613 | 208 | -4,706 | -2,856 |
| Interest Expense | 794 | 917 | 980 | 1,152 | 1,305 |
| Other Income | 0 | -340 | 0 | -1,290 | -915 |
| Pre-tax Income | -2,065 | -2,870 | -772 | -7,148 | -5,076 |
| Income Tax | -775 | -1,087 | -290 | -2,966 | -1,888 |
| Net Income Continuous | -1,290 | -1,783 | -482 | -4,182 | -3,188 |
| Net Income | $-1,290 | $-1,783 | $-482 | $-4,182 | $-3,188 |
| EPS Basic Total Ops | -0.20 | -0.28 | -0.08 | -0.65 | -0.50 |
| EPS Basic Continuous Ops | -0.20 | -0.28 | -0.08 | -0.65 | -0.50 |
| EPS Diluted Total Ops | -0.20 | -0.28 | -0.08 | -0.65 | -0.50 |
| EPS Diluted Continuous Ops | -0.20 | -0.28 | -0.08 | -0.65 | -0.50 |
| EBITDA(a) | $-176 | $-593 | $1,181 | $-3,939 | $-1,859 |